The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
about
An Efficient Site-Specific Method for Irreversible Covalent Labeling of Proteins with a Fluorophore.Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma.
P2860
The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
@ast
The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
@en
type
label
The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
@ast
The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
@en
prefLabel
The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
@ast
The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
@en
P2093
P2860
P356
P1433
P1476
The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.
@en
P2093
Eduardo Salido
Josef Rüschoff
Juana V Martín-López
Miguel Andújar
Richard Fishel
Sanghee Lee
Vicente Medina-Arana
Ysamar Barrios
P2860
P304
P356
10.1093/CARCIN/BGS199
P407
P50
P577
2012-06-27T00:00:00Z